📝 TruAlt Bioenergy Limited — results explained
Quarter ended June 2026 (Q1 FY27)
TruAlt Bioenergy Limited reported revenue of ₹616 crore for the quarter ended June 2026 (Q1 FY27), up 109.5% from ₹294 crore in the same quarter last year, and up 2.1% sequentially over the March 2026 quarter.
Net profit stood at ₹55 crore. Earnings per share (EPS) came in at ₹6.41.
Operating profit stood at ₹127 crore — an operating margin (OPM) of 20.6%, compared with 11.9% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, TruAlt Bioenergy Limited posted revenue of ₹1,705 crore, with a net profit of ₹80 crore.
On a trailing-twelve-month (TTM) basis, revenue stands at ₹2,027 crore with a net profit of ₹135 crore.
Valuation snapshot
At the current price of ₹441.35, TRUALT has a market capitalisation of ₹3,785 crore and a trailing P/E of about 28.0.
Within the Other Agricultural Products industry, it is the 2nd-largest of the 59 companies we track by market value.
Shareholding pattern
As of Sep 2026, promoters held 71.38%, foreign institutional investors (FIIs) 0.63%, domestic institutional investors (DIIs) 9.09%, public shareholders 18.91% of TruAlt Bioenergy Limited.